2023
DOI: 10.1016/j.abb.2023.109762
|View full text |Cite
|
Sign up to set email alerts
|

Enzymes in riboflavin biosynthesis: Potential antibiotic drug targets

Juthamas Jaroensuk,
Litavadee Chuaboon,
Chatchai Kesornpun
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 101 publications
0
0
0
Order By: Relevance
“…The enzymes involved in its synthesis in bacteria represent an intriguing target as they are not found in mammalian cells, which import riboflavin rather than synthesize it. Possible targets include GTP cyclohydrolase II (GCH II), lumazine synthase (LS), riboflavin synthase (RFS), FAD synthetase (FADS), and FMN riboswitch, as reviewed in 2023 . A range of early stage inhibitors are described in this review, including the example of ribocil C ( 96 ) (Figure ), which is a highly selective inhibitor of the FMN riboswitch. The Hergenrother eNTRy rules , were applied to attempt to improve G–ve uptake, producing more active ribocil C-PA ( 97 ) .…”
Section: Compounds With New Antibacterial Modes Of Actionmentioning
confidence: 99%
“…The enzymes involved in its synthesis in bacteria represent an intriguing target as they are not found in mammalian cells, which import riboflavin rather than synthesize it. Possible targets include GTP cyclohydrolase II (GCH II), lumazine synthase (LS), riboflavin synthase (RFS), FAD synthetase (FADS), and FMN riboswitch, as reviewed in 2023 . A range of early stage inhibitors are described in this review, including the example of ribocil C ( 96 ) (Figure ), which is a highly selective inhibitor of the FMN riboswitch. The Hergenrother eNTRy rules , were applied to attempt to improve G–ve uptake, producing more active ribocil C-PA ( 97 ) .…”
Section: Compounds With New Antibacterial Modes Of Actionmentioning
confidence: 99%